|
Patent Windfall Coming, But Market Challenges Remain, Analyst Says
Wall Street’s outlook for generic companies includes more generic market penetration and a wave of patent expirations, but an influx of authorized generics will hurt the profitability now enjoyed by firms with marketing exclusivity, says one Wall Street observer. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives